A detailed history of Ameritas Advisory Services, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 27 shares of UTHR stock, worth $12,592. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 32 15.63%
Holding current value
$12,592
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$274.7 - $438.75 $1,373 - $2,193
-5 Reduced 15.63%
27 $11,000
Q2 2025

Jul 21, 2025

BUY
$276.47 - $328.4 $8,847 - $10,508
32 New
32 $9,000
Q1 2023

Apr 28, 2023

BUY
$212.99 - $276.17 $1,064 - $1,380
5 New
5 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.